| |
So how can MM keep price down AND buy all they can I'd like to know what ECON law of supply and demand this follows? Investor demand heavy, right? MM demand heavy right? And price goes down? I think something fishy with your reasoning and something fishy with this stock. FIRST, this news from the conference is NOT new, but old. We all knew PIII coming soon with big partners. We all knew insiders optimistic for last three years. We all knew 100% success with head and neck with NO side effects. What gives here? A competing drug or rotten apple at IMCL they do not want to tell us about. I am long now, but lightened up above $10. Below $8 we see buying; above $10 we see selling...simple as that. I think if all is good at IMCL and no competing drug to worry us, then what is really happening is investors are skeptical of biotech in general and waiting for proof positive. This rationale I'm a little skeptical of though because if all is great at IMCL you KNOW word gets out, and price starts moving long before public gets any news to sink teeth into.
Long but confused and smelling a rat,
Jackson |
|
